QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met 期刊论文 CANCER SCIENCE, 2019, 页码: 11 作者:  Tong, Mengya;  Gao, Mingzhao;  Xu, Yongping;  Fu, Li;  Li, Yun 收藏  |  浏览/下载：21/0  |  提交时间：2020/07/01 AZD9291  c-Met ADC  c-Met overexpression  resistance  SHR-A1403   Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants 期刊论文 CANCER SCIENCE, 2019, 页码: 9 作者:  Gao, Mingzhao;  Zhu, Hongmei;  Fu, Li;  Li, Yun;  Bao, Xubin 收藏  |  浏览/下载：17/0  |  提交时间：2020/07/01 AG-221  IDH2  leukemia  R140Q  R172K   Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, invitro and in human tumor xenograft models 期刊论文 CANCER SCIENCE, 2019, 卷号: 110, 期号: 4, 页码: 1420-1430 作者:  Long, Fei;  He, Ye;  Fu, Haoyu;  Li, Yun 收藏  |  浏览/下载：20/0  |  提交时间：2020/07/01 breast cancer  CDK 4/6  drug resistance  palbociclib  SHR6390   Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials 期刊论文 CANCER SCIENCE, 2019, 卷号: 110, 期号: 3, 页码: 1064-1075 作者:  Wang, Lei;  Yang, Changyong;  Xie, Chengying;  Jiang, Jiahua;  Gao, Mingzhao 收藏  |  浏览/下载：22/0  |  提交时间：2020/07/01 antitumor activity  fluzoparib  pharmacokinetics  poly(ADP-ribose) polymerase  toxicity   WO3 nanosheets/g-C3N4 nanosheets’ nanocomposite as an effective photocatalyst for degradation of rhodamine B 期刊论文 Applied Physics A, 2019, 卷号: Vol.125 No.1 作者:  Senlin Deng;  Zebin Yang;  Guojun Lv;  Yongqiang Zhu;  Haichao Li 收藏  |  浏览/下载：18/0  |  提交时间：2019/11/21 Pharmacologic characterization of fluzoparib, a novel poly polymerase inhibitor undergoing clinical trials 期刊论文 Cancer Science, 2019, 卷号: Vol.110 No.3, 页码: 1064-1075 作者:  Lei Wang;  Changyong Yang;  Chengying Xie;  Jiahua Jiang;  Mingzhao Gao 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/13 antitumor activity  fluzoparib  pharmacokinetics  poly(ADP‐ribose) polymerase  toxicity   Preclinical characterization of SHR6390, a novel CDK 4/6 inhibitor, in vitro and in human tumor xenograft models. 期刊论文 Cancer science, 2019 作者:  Fei Long;  Ye He;  Haoyu Fu;  Yun Li;  Xubin Bao 收藏  |  浏览/下载：22/0  |  提交时间：2019/12/17 CDK  4/6  SHR6390  breast  cancer  drug  resistance  palbociclib   Pharmacologic Characterization of Fluzoparib, a Novel Poly polymerase Inhibitor Undergoing Clinical Trials. 期刊论文 Cancer science, 2019 作者:  Lei Wang;  Changyong Yang;  Chengying Xie;  Jiahua Jiang;  Mingzhao Gao 收藏  |  浏览/下载：14/0  |  提交时间：2019/12/13 PARP  Antitumor  activity  Fluzoparib  Pharmacokinetics  Toxicity   Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease 期刊论文 2019, 卷号: 69, 期号: 6, 页码: 2414-2426 作者:  Yan, Jinhua;  Yao, Bin;  Kuang, Hongyu;  Yang, Xubin;  Huang, Qin 收藏  |  浏览/下载：34/0  |  提交时间：2020/01/03 glucagon-like peptide-1 receptor agonist  liver fat index  magnetic resonance imaging  nonalcoholic fatty liver disease  type 2 diabetes mellitus   The Community Land Model Version 5: Description of New Features, Benchmarking, and Impact of Forcing Uncertainty 期刊论文 JOURNAL OF ADVANCES IN MODELING EARTH SYSTEMS, 2019, 卷号: 11, 期号: 12, 页码: 4245-4287 作者:  Lawrence David M.;  Fisher Rosie A.;  Koven Charles D.;  Oleson Keith W.;  Swenson Sean C. 收藏  |  浏览/下载：35/0  |  提交时间：2020/02/28 global land model  Earth System Modeling  carbon and nitrogen cycling  hydrology  benchmarking